Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HEPA - Hepion Pharma completes final dosing in multiple ascending dose study of CRV431

HEPA - Hepion Pharma completes final dosing in multiple ascending dose study of CRV431

Hepion Pharmaceuticals Inc.
  • Hepion Pharmaceuticals (NASDAQ:HEPA) announces that dosing has been completed in all subjects enrolled in the Phase 1b multiple ascending dose (MAD) study of CRV431.
  • More news on: Hepion Pharmaceuticals, Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Hepion Pharmaceuticals Inc.
Stock Symbol: HEPA
Market: NASDAQ
Website: hepionpharma.com
Menu
HEPA HEPA Quote HEPA Short HEPA News HEPA Articles HEPA Message Board
Get HEPA Alerts

News, Short Squeeze, Breakout and More Instantly...